January 04, 2016
2 min watch
Save

VIDEO: ‘Tremendously exciting’ abstracts show potential of CAR T cells for lymphoma

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ORLANDO, Fla. ― Marcela V. Maus, MD, PhD, reacts to two studies presented at the ASH Annual Meeting and Exposition that explored the use of chimeric antigen receptor T-cells for the treatment of lymphoma.